Pharmaceutical compositions with improved dissolution
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- TRANSFORM PHARMACEUTICALS INC
- Publication Date
- 2005-02-03
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions and methods for preparing same. BACKGROUND OF THE INVENTION Celecoxib (4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) is a substituted pyrazolylbenzenesulfonamide represented by the structure: Celecoxib belongs to the general class of non-steroidal anti-inflammatory drugs (NSAIDs). Unlike traditional NSAIDs, celecoxib is a selective inhibitor of cyclooxygenase II (COX-2) that causes fewer side effects when administered to a subject. The synthesis and use of celecoxib are further described in U.S. Pat. Nos. 5,466,823, 5,510,496, 5,563,165, 5,753,688, 5,760,068, 5,972,986, and 6,156,781, the contents of which are incorporated by reference in their entirety. Orally deliverable liquid formulations of celecoxib are discussed in U.S. Patent Application Publication No. 2002 / 0107250 in the name of Hariharan, et al., the contents of which are incorporated herein by reference...